Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol
- 17 August 2009
- Vol. 45 (5), 870-875
- https://doi.org/10.1016/j.bone.2009.07.015
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assaysAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2006
- Vitamin D and adult bone health in Australia and New Zealand: a position statementThe Medical Journal of Australia, 2005
- Vitamin D2Is Much Less Effective than Vitamin D3in HumansJournal of Clinical Endocrinology & Metabolism, 2004
- Issues of standardization and assay-specific clinical decision limits for the measurement of 25-hydroxyvitamin DThe American Journal of Clinical Nutrition, 2003
- Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic ImplicationsEndocrine Reviews, 2001
- Secondary Hyperparathyroidism in Patients from Western Australia with Hip Fracture: Relationship to Type of Hip Fracture, Renal Function, and Vitamin D DeficiencyJournal of the American Geriatrics Society, 1999
- Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2The American Journal of Clinical Nutrition, 1998
- Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or OlderNew England Journal of Medicine, 1997
- Vitamin D3and Calcium to Prevent Hip Fractures in Elderly WomenNew England Journal of Medicine, 1992
- Plasma 25-hydroxy vitamin D concentrations in patients with fractures of the femoral neck.BMJ, 1979